Supernus Pharmaceuticals (NASDAQ:SUPN)

CAPS Rating: 2 out of 5

Results 1 - 7 of 7

Recs

0
Member Avatar crashavoidance (99.87) Submitted: 7/29/2015 2:04:59 AM : Outperform Start Price: $8.03 SUPN Score: +111.88

Already done well with this but believe still some good upside if the two drugs still in development pan out (so far looks good but longer term / higher risk play until actually happens)

In the meantime, approach of adding ER (extended release) to already existing drugs & being able to sell at proprietary (not generic) price points should continue to grow steadily--given they continue to successfully defend patents without excessive legal fees.

R&D expenses will significantly increase across next couple Qtrs (trials related to two pipeline drugs) so might see some dips if Mr. Market over-reacts (providing opportunity to pick up more shares).

Also need to keep eye on SGA to ensure they aren't paying huge windfalls to sales. Given SUPN was split from Shire and thats where most sales Mgmt came from, they have some history / expectation of big $$.

Recs

0
Member Avatar mirqce (< 20) Submitted: 11/21/2014 7:24:48 PM : Outperform Start Price: $8.94 SUPN Score: +102.93

two new drugs two more in pipe line low debt some cash good management

Recs

0
Member Avatar manirg (96.29) Submitted: 8/13/2014 4:22:36 PM : Outperform Start Price: $9.03 SUPN Score: +95.73

low valuation

Recs

0
Member Avatar cavemantrader (79.35) Submitted: 12/24/2013 10:58:05 AM : Outperform Start Price: $8.69 SUPN Score: +95.83

The FDA approved United Therapeutics' drug Orenitram Friday evening. The drug is intended to treat pulmonary arterial hypertension. This could bring SUPN at least 250 million going forward, yet the stock barely moved to the upside. It appears a large number of funds were not expecting the extremely positive development and were shorting the stock, but after some fund manipulation to cover and mitigate losses, expect shares to breakout to the double digits in the near term.

Recs

0
Member Avatar ptanabe (65.97) Submitted: 7/31/2013 6:46:48 PM : Outperform Start Price: $6.87 SUPN Score: +141.89

k

Recs

0
Member Avatar 21Emoney21 (< 20) Submitted: 10/19/2012 2:27:45 PM : Outperform Start Price: $13.03 SUPN Score: -2.48

Expect to see FDA approval today on new drug

Recs

0
Member Avatar SamsaricSufferer (48.43) Submitted: 7/4/2012 8:35:17 PM : Outperform Start Price: $9.69 SUPN Score: +38.16

PDUFA coming up

Results 1 - 7 of 7

Featured Broker Partners


Advertisement